Bitcoin Cash vs Enzyme — how do they compare? Bitcoin Cash trades at Rp3,686,225 (market cap Rp73,9T, Rp3,06T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Bitcoin Cash is far larger — about 550958× Enzyme's market cap, and Bitcoin Cash's supply is capped (20,1M / 21M BCH (96%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bitcoin Cash for 67 Days and Enzyme for 29 Days on average.
| BCH | MLN | |
|---|---|---|
Market Cap | Rp73,9T | Rp134,13M |
Volume (24h) | Rp3,06T | Rp104,56M |
Circulating Supply | 20,1M / 21M BCH (96%) | 3,3M MLN |
Typical Hold Time | 67 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Bitcoin Cash (BCH) is trading at Rp 3,818,969 with a market cap of Rp 76.35 trillion, showing bearish technical signals from moving averages and a neutral stance from oscillators. The price is near the pivot point of Rp 3,810,616, with support at Rp 3,765,967 and resistance at Rp 3,839,212. Recent news highlights increased accessibility through broker integrations like Interactive Brokers adding new tokens, though no major protocol updates were noted. On-chain metrics indicate 96% of max supply is circulating, with an average hold time of 67 days.
Overall outlook is cautious due to bearish technical indicators and lack of fundamental catalysts. Key opportunities include potential rebounds from support levels and broader crypto adoption trends. Major risks involve high volatility, regulatory uncertainty, and low liquidity depth, which could amplify price swings. Investors should monitor trading volume and network activity for signs of renewed interest.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Bitcoin Cash (BCH) is a peer-to-peer electronic cash system that aims to become sound global money with fast payments, micro fees, privacy, and high transaction capacity (big blocks). With a limited total supply of 21 million coins, Bitcoin Cash is provably scarce and, like physical cash, can be easily spent.
Read more on BCH →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →